Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Barbara A. Brown Elliott"'
Autor:
Shamira J. Shallom, Hervé Tettelin, Prabha Chandrasekaran, In Kwon Park, Sonia Agrawal, Kriti Arora, Lisa Sadzewicz, Aaron M. Milstone, Moira L. Aitken, Barbara A. Brown-Elliott, Richard J. Wallace, Elizabeth P. Sampaio, Michael Niederweis, Kenneth N. Olivier, Steven M. Holland, Adrian M. Zelazny
Publikováno v:
Virulence, Vol 14, Iss 1 (2023)
ABSTRACTBackground Mycobacterium abscessus subspecies massiliense (M. massiliense) is increasingly recognized as an emerging bacterial pathogen, particularly in cystic fibrosis (CF) patients and CF centres’ respiratory outbreaks. We characterized g
Externí odkaz:
https://doaj.org/article/1d3e83e79bc44125bc0ecce45076b372
Autor:
Jay Peters, Diego Jose Maselli, Mandeep Mangat, Jacqueline J. Coalson, Cecilia Hinojosa, Luis Giavedoni, Barbara A. Brown-Elliott, Edward Chan, David Griffith
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Rationale Mycobacterium avium complex, is the most common nontuberculous mycobacterial respiratory pathogen in humans. Disease mechanisms are poorly understood due to the absence of a reliable animal model for M. avium complex pulmonary disease. Obje
Externí odkaz:
https://doaj.org/article/ab08aa9e7d7e4e6ba39cc55159659873
Autor:
Bock-Gie Jung, Kristin Dean, Carly Wadle, Buka Samten, Deepak Tripathi, Richard J. Wallace, Barbara A. Brown-Elliott, Torry Tucker, Steven Idell, Julie V. Philley, Ramakrishna Vankayalapati
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT Nontuberculous mycobacteria (NTM) cause pulmonary disease in individuals without obvious immunodeficiency. This study was initiated to gain insight into the immunological factors that predispose persons to NTM pulmonary disease (NTMPD). Bloo
Externí odkaz:
https://doaj.org/article/d0c09b0784ff4487887debbe4abb3cea
Autor:
Rebecca M. Davidson, Jeanne B. Benoit, Sara M. Kammlade, Nabeeh A. Hasan, L. Elaine Epperson, Terry Smith, Sruthi Vasireddy, Barbara A. Brown-Elliott, Jerry A. Nick, Kenneth N. Olivier, Adrian M. Zelazny, Charles L. Daley, Michael Strong, Richard J. Wallace
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Recent studies have characterized a dominant clone (Clone 1) of Mycobacterium abscessus subspecies massiliense (M. massiliense) associated with high prevalence in cystic fibrosis (CF) patients, pulmonary outbreaks in the United States (US) a
Externí odkaz:
https://doaj.org/article/65f02a743ac340e2baeb45d175365d25
Autor:
Bock-Gie Jung, Buka Samten, Kristin Dean, Richard J Wallace, Barbara A Brown-Elliott, Torry Tucker, Steven Idell, Julie V Philley, Ramakrishna Vankayalapati
Publikováno v:
PLoS Pathogens, Vol 18, Iss 4, p e1010454 (2022)
Nontuberculous mycobacteria (NTM) infection is common in patients with structural lung damage. To address how NTM infection is established and causes lung damage, we established an NTM mouse model by intranasal inoculation of clinical isolates of M.
Externí odkaz:
https://doaj.org/article/931256ce769b45d99673d1b41efe2f81
Autor:
Barbara A. Brown-Elliott, Susan Molina, Travis Fly, Ousman Njie, Patricia Stribley, Dominic Stephenson, Richard J. Wallace, Jr., John D. Perry
Publikováno v:
Heliyon, Vol 5, Iss 10, Pp e02684- (2019)
This single center study assessed the performance of a novel solid rapidly-growing mycobacteria (RGM) medium for the recovery of nontuberculous mycobacteria (NTM), especially Mycobacterium abscessus complex, in patients with underlying bronchiectasis
Externí odkaz:
https://doaj.org/article/f0e735d5b6e9490ca769883ee46f6d32
Autor:
Susan B Fogelson, Alvin C Camus, W Walter Lorenz, Ravikiran Vasireddy, Sruthi Vasireddy, Terry Smith, Barbara A Brown-Elliott, Richard J Wallace, Nabeeh A Hasan, Udo Reischl, Susan Sanchez
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0214274 (2019)
Mycobacterium chelonae is a member of the Mycobacterium chelonae-abscessus complex and a cause of opportunistic disease in fish, reptiles, birds, and mammals including humans. Isolates in the complex are often difficult to identify and have differing
Externí odkaz:
https://doaj.org/article/c5cc4fa611334ad0b53914c2fd3d9959
Publikováno v:
Antimicrob Agents Chemother
Nontuberculous mycobacteria (NTM) infections are increasing worldwide. Mycobacterium avium complex (MAC) and the M. abscessus species are the most commonly cultured NTM and treatment options are limited, especially for the M. abscessus species. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::612c1b792ec1e6002922473c6558f804
https://europepmc.org/articles/PMC9664839/
https://europepmc.org/articles/PMC9664839/
Autor:
Timothy R. Aksamit, Richard J. Wallace, Dayton W. Yuen, Kozo Morimoto, Wouter Hoefsloot, David E. Griffith, Doreen Addrizzo-Harris, Kevin L. Winthrop, Kevin C. Mange, Monika Ciesielska, Rachel Thomson, Jakko van Ingen, Chris Coulter, Stephen K. Field, Patrick A. Flume, Barbara A. Brown-Elliott
Publikováno v:
Chest. 160:831-842
Background: In the CONVERT study, treatment with amikacin liposome inhalation suspension (ALIS) added to guideline-based therapy (GBT) met the primary end point of increased culture conversion by month 6 in patients with treatment-refractory Mycobact
Autor:
Charles L. Daley, Rebecca M. Davidson, Sara M. Kammlade, Richard J. Wallace, Jeanne Benoit, Jerry A. Nick, Barbara A. Brown-Elliott, Kenneth N. Olivier, Adrian M. Zelazny, Michael J. Strong, Sruthi Vasireddy, Nabeeh A. Hasan, Terry Smith, L. Elaine Epperson
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Recent studies have characterized a dominant clone (Clone 1) of Mycobacterium abscessus subspecies massiliense (M. massiliense) associated with high prevalence in cystic fibrosis (CF) patients, pulmonary outbreaks in the United States (US) and United